Luye Pharma Group today announced that Shandong Boan Biotechnology Co. Ltd. (Boan Biotech) has completed the first patient dosing in the phase Ⅲ clinical trial for LY09004 in China. As a key area for...
Luye Pharma Group announced that its subsidiary, Shandong Boan Biotechnology Co. Ltd. (Boan Biotech), has received a further RMB 195 million in investments from investors including CCB International a...
Luye Pharma Group today announced that all subjects have been enrolled for the phase I clinical trial in China for LY-CovMab, an innovative antibody product developed by Shandong Boan Biotechnology Co...
Luye Pharma Group announced the conclusion of a round of strategic financing for its subsidiary, Shandong Boan Biotechnology Co., Ltd. (Boan Biotech), bringing cumulative financing to RMB 682 million....
No.39 Keji Avenue High-Tech Industrial Development Zone Yantai, Shandong Province, China
（86）0535-4379111
boanbiotech@boan-bio.com
Follow me
鲁公网安备37069102000284
ICP备：鲁ICP备2021004064号-1
